NANDROLONE DECANOATE 100 MG INJECTION I.P / 1 ML
Date:

NANDROLONE DECANOATE 100 MG INJECTION I.P / 1 ML

  1. Name of the medicinal product

    DecaDuralin 50mg/ml

  1. Qualitative and quantitative composition

    Each ampoule contains 1 ml of 50 mg/ml nandrolonedecanoateFor the full list of excipients, see section 6.1.

  1. Pharmaceutical form

    Solution for injection

    Clear, yellow, oily solution

Adverse Reactions

Hepatic: 
Hepatocellular neoplasms and peliosis hepatis have been reported in association with long-term androgenic anabolic steroid therapy (see WARNINGS section).

Genitourinary System: 
In men.

  1. Prepubertal: Phallic enlargement and increased frequency of erections.
  2. Postpubertal: Inhibition of testicular function, testicular atrophy and oligospermia, impotence, chronic priapism, epididymitis and bladder irritability.

In women: Clitoral enlargement, menstrual irregularities. In both sexes: Increased or decreased libido.

CNS: 
Habituation, excitation, insomnia, depression.

Gastrointestinal: 
Nausea, vomiting, diarrhea.

Hematologic: 
Bleeding in patients on concomitant anticoagulant therapy (see PRECAUTIONS, Drug Interactions).

Breast: 
Gynecomastia.

Larynx: 
Deepening of the voice in women.

Hair: 
Hirsutism and male pattern of baldness in women.

Skin: 
Acne (especially in women and prepubertal boys.)

Skeletal: 
Premature closure of epiphyses in children (see PRECAUTIONS, Pediatric use).